Browse the corpus

Gastric resection for malignancy, whether performed via traditional open surgery or minimally invasive techniques, such as laparoscopic or robotic-assisted gastrectomy, remains a cornerstone in the management of gastric cancer. This is a critical procedure in managing gastric cancer, aiming to remove tumors while preserving healthy tissue and function completely. Surgical options for gastric cancer, including total, proximal, distal, and pylorus-preserving distal gastrectomies, are tailored to tumor location, extent, and patient factors, aiming for complete tumor removal while preserving healthy tissue and function. Lymph node dissection is frequently required; advanced cases of gastric cancer may also require multivisceral resection to achieve optimal outcomes. Postoperative outcomes and long-term survival depend on factors such as tumor stage, patient fitness, and the extent of surgical intervention. Furthermore, emerging modalities such as endoscopic submucosal dissection are expanding treatment options and enhancing outcomes for specific patients with early-stage disease. This activity provides a comprehensive understanding of the principles, techniques, and nuances of gastric resection for malignancy, addressing preoperative evaluation, surgical planning, intraoperative decision-making, and tailored postoperative management. In addition, this activity also fosters interdisciplinary teamwork and knowledge exchange among healthcare providers, enhancing clinical skills, expanding treatment options, and promoting collaboration across disciplines to improve outcomes for patients with gastric cancer through evidence-based practice and multidisciplinary care. Objectives: Identify appropriate candidates for gastric resection based on tumor characteristics, disease stage, and patient factors. Implement evidence-based protocols for preoperative evaluation, surgical planning, and postoperative management of gastric resection patients. Apply knowledge of emerging modalities, such as endoscopic submucosal dissection, to expand treatment options for early-stage gastric cancer. Collaborate with interdisciplinary teams to ensure seamless care transitions for patients undergoing gastric resection, optimizing their overall care experience. Access free multiple choice questions on this topic.

Gastric cancer represents a significant global health challenge, ranking as the fifth most common cancer worldwide and the third leading cause of cancer-related mortality.[1] Annually, there are over 1 million new cases globally, with approximately 27,500 new diagnoses in the United States alone.[2][3] The reported incidence stands at 5.6%, with a mortality rate of 7.7%, underscoring the need for effective management strategies.[4] Advanced gastric cancer accounts for 50% to 80% of all gastric cancer cases, with many patients (35%–51%) failing to achieve desired responses to neoadjuvant chemotherapy and 15% experiencing tumor progression.[5][6] In Western populations, a multimodal approach has become the standard response to these challenges, combining innovative combinations of chemotherapeutic agents, radiotherapies, and immunomodulatory drugs tailored to individual patient and tumor characteristics.[7][8] This personalized approach aims to minimize treatment-related toxicities while maximizing the effectiveness of conventional therapeutic strategies.[9] However, despite these advancements, radical en bloc surgical resection of the tumor with concomitant lymph node dissection remains the cornerstone of management.[10][11] Surgical options for gastric cancer resection include total, proximal, distal, and pylorus-preserving distal gastrectomies. The choice of surgical approach for gastric adenocarcinoma depends on factors such as where the epicenter of the tumor resides, the extent of stomach involvement, histological subtype, and genomic etiology. Given that gastric cancer is primarily a locoregional disease, the primary objective of surgery is to remove the primary tumor with a clear longitudinal and circumferential resection margin, preferably with a minimum distance of 5 cm from the palpable edge of the tumor. This involves achieving R0 resection, which may require combined organ resection, if necessary, along with lymph node dissection. Subsequently, the surgery aims to restore intestinal and biliary continuity safely to ensure sufficient nutritional intake. In cases of more extensive disease, selected patients may benefit from multivisceral resection (MVR) or cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC).

Surgical options for gastric cancer resection include total, proximal, distal, and pylorus-preserving distal gastrectomies. The choice of surgical approach for gastric adenocarcinoma depends on factors such as where the epicenter of the tumor resides, the extent of stomach involvement, histological subtype, and genomic etiology. Given that gastric cancer is primarily a locoregional disease, the primary objective of surgery is to remove the primary tumor with a clear longitudinal and circumferential resection margin, preferably with a minimum distance of 5 cm from the palpable edge of the tumor. This involves achieving R0 resection, which may require combined organ resection, if necessary, along with lymph node dissection. Subsequently, the surgery aims to restore intestinal and biliary continuity safely to ensure sufficient nutritional intake. In cases of more extensive disease, selected patients may benefit from multivisceral resection (MVR) or cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Traditionally, open gastrectomy has been the predominant method for gastric cancer resection. However, in recent years, minimally invasive surgical (MIS) techniques, such as laparoscopic gastrectomy and robotic-assisted gastrectomy, have gained popularity.[12]  Proponents of MIS tout its benefits, including decreased morbidity, accelerated recovery, and improved cosmetic outcomes.[13]  However, the selection of surgical approach remains multifactorial and is influenced by patient characteristics, disease pathology, and institutional expertise. Although MIS techniques offer compelling advantages, open gastrectomy retains its role in specific scenarios, underscoring the importance of individualized care in gastric cancer management.[14]

Traditionally, open gastrectomy has been the predominant method for gastric cancer resection. However, in recent years, minimally invasive surgical (MIS) techniques, such as laparoscopic gastrectomy and robotic-assisted gastrectomy, have gained popularity.[12]  Proponents of MIS tout its benefits, including decreased morbidity, accelerated recovery, and improved cosmetic outcomes.[13]  However, the selection of surgical approach remains multifactorial and is influenced by patient characteristics, disease pathology, and institutional expertise. Although MIS techniques offer compelling advantages, open gastrectomy retains its role in specific scenarios, underscoring the importance of individualized care in gastric cancer management.[14] Since its inception in 1994, laparoscopic gastrectomy has evolved into a well-established surgical modality for early gastric carcinoma. Numerous multicenter, prospective, randomized clinical trials have demonstrated long-term oncological and survival outcomes comparable to open gastrectomy. Therefore, laparoscopic gastrectomy is considered a well-established surgical approach to managing early gastric carcinoma.[15][16] Moreover, laparoscopic gastrectomy is increasingly recognized as a feasible, safe, and effective approach for radical resection of locally advanced distal gastric cancer.[17][18] Despite these advancements, debates persist regarding disparities in postoperative and oncological outcomes between laparoscopic and open gastrectomy, alongside the technical intricacies and learning curve associated with laparoscopic techniques.[19][20] Robotic-assisted surgery presents a promising solution to address the limitations of conventional laparoscopy in managing gastric cancers. Advantages include 3-dimensional vision, enhanced skill acquisition, increased dexterity, improved mobility, and better ergonomics for surgeons.[14] However, despite these benefits, the adoption of robotic-assisted gastrectomy in upper gastrointestinal surgery, particularly for gastric cancer resections, has been slower compared to other specialties. Limited high-quality data, primarily from retrospective studies, hinders a comprehensive evaluation of robotic-assisted gastrectomy's role in gastric tumor resection, highlighting the need for further research to elucidate its long-term oncological outcomes and efficacy.[21]

Robotic-assisted surgery presents a promising solution to address the limitations of conventional laparoscopy in managing gastric cancers. Advantages include 3-dimensional vision, enhanced skill acquisition, increased dexterity, improved mobility, and better ergonomics for surgeons.[14] However, despite these benefits, the adoption of robotic-assisted gastrectomy in upper gastrointestinal surgery, particularly for gastric cancer resections, has been slower compared to other specialties. Limited high-quality data, primarily from retrospective studies, hinders a comprehensive evaluation of robotic-assisted gastrectomy's role in gastric tumor resection, highlighting the need for further research to elucidate its long-term oncological outcomes and efficacy.[21] Despite numerous randomized controlled trials and standard pairwise meta-analyses, consensus on the oncological and surgical safety of laparoscopic and robotic-assisted gastrectomy compared to open gastrectomy for gastric carcinoma resection remains elusive.[22][23][24] Recent trials have reported short-term postoperative and survival outcomes following robotic-assisted gastrectomy, sparking optimism among gastroesophageal surgeons that these minimally invasive approaches may enhance patient outcomes.[22][23] However, further research is necessary to establish a definitive consensus on the efficacy and safety of laparoscopic gastrectomy and robotic-assisted gastrectomy relative to open gastrectomy in managing gastric cancer. Another emerging modality for treating early gastric cancer is endoscopic submucosal dissection (ESD), particularly when lymph node metastasis risk is low. In contrast to surgical gastrectomy, ESD offers a minimally invasive approach with significant benefits, such as preserving the entire stomach and maintaining the patient's quality of life. Despite some drawbacks, this technique signifies a notable advancement in the management of early gastric cancer, offering patients effective treatment while minimizing the impact on their overall well-being.[25]

Another emerging modality for treating early gastric cancer is endoscopic submucosal dissection (ESD), particularly when lymph node metastasis risk is low. In contrast to surgical gastrectomy, ESD offers a minimally invasive approach with significant benefits, such as preserving the entire stomach and maintaining the patient's quality of life. Despite some drawbacks, this technique signifies a notable advancement in the management of early gastric cancer, offering patients effective treatment while minimizing the impact on their overall well-being.[25] The evolution from traditional open procedures to minimally invasive techniques reflects a significant advancement in the surgical management of gastric malignancies, offering patients improved outcomes and a better quality of life. This activity explores the various surgical approaches for treating gastric cancer, discussing their advantages, limitations, and emerging trends in the field.

High-risk patients are more susceptible to complications, which can lead to considerable morbidity or even mortality. Risk factors such as tobacco use, preoperative malnutrition, total gastrectomy, nonmalignant indications for resection, and blood transfusions have been associated with a higher risk of morbidity.[49] As with any surgical procedure, gastric resection carries inherent intraoperative risks, including bleeding and potential injury to surrounding structures, such as iatrogenic spleen injury.[58] Despite significant advancements in surgical techniques, anesthesiology, postoperative care, and interventional radiology for gastric cancer, gastrectomy still carries risks of severe postoperative complications such as anastomotic leakage and intraabdominal abscess. These complications can impede recovery, delay the initiation of adjuvant chemotherapy, and compromise quality of life. Moreover, postoperative complications have been shown to adversely affect the overall and recurrence-free survival of patients after curative gastrectomy for gastric cancer. Hence, certain complications can have catastrophic effects on both short- and long-term outcomes. Recently reported overall morbidity rates after resection for gastric cancer range from 17.4% to 24.5% in East Asia, with slightly higher rates of 13.6% to 46% in Western countries.[59] Complications Associated with Gastric Resection The most common postgastrectomy complications following gastric resection include nutritional deficiencies, dumping syndrome, small gastric remnant, postvagotomy diarrhea, delayed gastric emptying, afferent or efferent loop syndrome, Roux stasis, and bile reflux gastritis.[60] Postoperative complications can be categorized as either early (occurring within days to weeks) or late (after 6 weeks), as described below. Early complications: These complications include anastomotic leak, bowel obstruction, postoperative ileus, duodenal stump blowout, delayed gastric emptying, surgical site infection, and intraabdominal infection. Late complications: Late complications arising after gastric resection encompass various challenges that can significantly impact a patient's well-being and postoperative management.

Early complications: These complications include anastomotic leak, bowel obstruction, postoperative ileus, duodenal stump blowout, delayed gastric emptying, surgical site infection, and intraabdominal infection. Late complications: Late complications arising after gastric resection encompass various challenges that can significantly impact a patient's well-being and postoperative management. Bile reflux gastritis: This condition occurs due to the chronic exposure of the gastric remnant to biliopancreatic secretions caused by the loss of the pylorus. Symptoms include epigastric pain, nausea with vomiting, and pain that is only partially associated with meals. Diagnosis is often made via endoscopy, revealing bile and inflammation in the distal stomach, or through a hepatobiliary iminodiacetic acid (HIDA) scan showing bile pooling in severe cases. Surgical correction is the mainstay of treatment and consists of conversion to Roux-en-Y gastrojejunostomy with at least a 60-cm Roux limb to divert biliopancreatic contents away from the gastric remnant.[60] Dumping syndrome: This condition encompasses a constellation of gastrointestinal and vasomotor symptoms triggered by the rapid emptying of hyperosmolar gastric contents into the proximal intestine. Early dumping begins within 30 minutes of food consumption and manifests with both gastrointestinal and vasomotor symptoms, including abdominal pain, diarrhea, bloating, nausea, flushing, palpitations, diaphoresis, tachycardia, syncope, and hypertension. Late dumping occurs 2 to 4 hours after a meal and consists primarily of vasomotor symptoms associated with hypoglycemia. Treatment modalities include dietary adjustments, medical treatment with somatostatin analogs, or surgical interventions for refractory cases.[60]

Dumping syndrome: This condition encompasses a constellation of gastrointestinal and vasomotor symptoms triggered by the rapid emptying of hyperosmolar gastric contents into the proximal intestine. Early dumping begins within 30 minutes of food consumption and manifests with both gastrointestinal and vasomotor symptoms, including abdominal pain, diarrhea, bloating, nausea, flushing, palpitations, diaphoresis, tachycardia, syncope, and hypertension. Late dumping occurs 2 to 4 hours after a meal and consists primarily of vasomotor symptoms associated with hypoglycemia. Treatment modalities include dietary adjustments, medical treatment with somatostatin analogs, or surgical interventions for refractory cases.[60] Afferent and efferent limb syndrome: These are well-established complications of gastric resection. Afferent loop syndrome, albeit rare, arises from various causes such as internal hernia, marginal ulceration, adhesions, recurrent cancer, or intussusception, particularly in patients with Billroth II gastrectomy. Symptoms include immediate postprandial pain and cramping, followed by vomiting that completely relieves symptoms. Detecting acute afferent loop syndrome within 1 to 2 weeks postoperatively is crucial, given its potential to lead to a duodenal stump leak. Conversely, efferent loop syndrome, characterized by mechanical obstruction at the gastrojejunostomy, can stem from various factors such as anastomotic stricture, marginal ulceration, recurrent cancer, or adhesions. The symptoms of this condition typically include bilious emesis or delayed gastric emptying.[60] Internal hernia or Peterson hernia: These are a known cause of acute abdominal pain in patients with gastric resection and Roux-en-Y reconstruction. In these cases, 3 common types of transmesenteric hernias are observed. Transmesocolic hernias involve herniation through the surgical defect in the transverse mesocolon, where the alimentary limb descends. Peterson hernias occur through the potential space between the Roux limb mesentery and the mesocolon, situated behind the alimentary limb. Lastly, bowel herniation can occur through the small bowel mesentery, particularly at the jejunostomy site.[61] Additional complications include anastomotic stricture, malnutrition and nutritional deficiencies, marginal ulcers, and cancer recurrence.[61]

Enhancing patient-centered care, outcomes, safety, and team performance related to gastric resection for malignancy requires a collaborative effort among physicians, advanced practitioners, nurses, pharmacists, and other healthcare professionals. Physicians and advanced practitioners must possess strong surgical skills, including proficiency in various gastrectomy techniques and assessing tumor extent and patient suitability for surgery. They should implement evidence-based perioperative management strategies, such as optimizing nutrition and pain control, to enhance patient outcomes. Effective interprofessional communication among healthcare team members is essential for ensuring seamless care coordination, sharing pertinent patient information, and promptly addressing any concerns or changes in the patient's condition. Nurses are critical in providing holistic care to patients undergoing gastric resection. They provide essential patient education, prepare patients for surgery, oversee postoperative care, and monitor for complications. Pharmacists contribute to ensuring appropriate medication management, including pain control and infection prevention postoperatively. Collaboration among all healthcare team members is essential for effective care coordination, ensuring that each patient receives comprehensive, individualized care tailored to their needs and preferences. Through cohesive teamwork, healthcare professionals can optimize patient-centered care, improve outcomes, enhance patient safety, and elevate team performance in managing gastric malignancies through gastric resection

Effective communication and coordination among the interprofessional healthcare team are essential to optimize gastric resection outcomes and reduce morbidity and mortality associated with gastric resection. Nursing staff must communicate effectively during handoff to report a history of gastric resection and associated comorbidities. The availability of specialized nurses for support and education is also crucial. Nurses should possess a thorough understanding of potential complications such as bowel obstruction, anastomotic leak, postoperative bleeding, duodenal stump blowout, delayed gastric emptying, and malnutrition. Additionally, promptly identifying patients presenting with acute abdominal pain, nausea, or vomiting can prompt nurses to contact surgical services promptly for further evaluation and intervention.